CHINA PHARMA HOLDINGS, INC. Debt Instrument, Convertible, Conversion Price
CHINA PHARMA HOLDINGS, INC. (CPHI) had Debt Instrument, Convertible, Conversion Price of $0.28 per share as of 2023-06-23, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2023-08-14
- 2023-06-23: Debt Instrument, Convertible, Conversion Price $0.28.
- 2023-06-06: Debt Instrument, Convertible, Conversion Price $0.27.
- 2023-05-24: Debt Instrument, Convertible, Conversion Price $0.25.
- 2023-05-01: Debt Instrument, Convertible, Conversion Price $0.26.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2023-06-23 | $0.28 10-Q · filed 2023-08-14 |
| 2023-06-06 | $0.27 10-Q · filed 2023-08-14 |
| 2023-05-24 | $0.25 10-Q · filed 2023-08-14 |
| 2023-05-01 | $0.26 10-Q · filed 2023-08-14 |
| 2023-04-07 | $0.28 10-Q · filed 2023-08-14 |
| 2023-03-02 | $0.57 10-Q · filed 2023-08-14 |
| 2023-01-18 | $0.76 10-Q · filed 2023-08-14 |
| 2023-01-05 | $0.76 10-Q · filed 2023-08-14 |
| 2022-09-30 | $3.00 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.00 10-Q · filed 2022-08-11 |
| 2022-04-19 | $15.00 10-K · filed 2023-03-30 |
| 2022-03-31 | $3.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |